Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | NINL | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |
mRNA | LRRC34 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |
mRNA | ZNF529 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | FAM171A2 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
mRNA | SP4 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
mRNA | KCNH3 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-09 |
mRNA | RP11-1212A22.4 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
mRNA | BSN | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | YLPM1 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |